Nitrazepam



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Sleep Apnoea Syndrome 33.3%
Insomnia Related To Another Mental Condition 22.2%
Agitation 11.1%
Depression 11.1%
Respiratory Tract Infection 11.1%
Reversal Of Sedation 11.1%
Depression 33.3%
Suicide Attempt 33.3%
Urinary Incontinence 33.3%
Secondary
Product Used For Unknown Indication 32.4%
Schizophrenia 13.9%
Drug Use For Unknown Indication 9.3%
Depression 8.0%
Insomnia 5.9%
Constipation 3.6%
Epilepsy 3.5%
Hiv Infection 2.7%
Pyrexia 2.6%
Ill-defined Disorder 2.2%
Drug Dependence 2.1%
Schizophrenia, Paranoid Type 2.0%
Intentional Overdose 1.9%
Antiretroviral Therapy 1.7%
Bipolar I Disorder 1.7%
Anxiety 1.5%
Sleep Disorder 1.4%
Pneumonia 1.3%
Pain 1.2%
Herpes Zoster 1.2%
Suicide Attempt 16.8%
Toxicity To Various Agents 10.9%
Overdose 6.5%
Drug Rash With Eosinophilia And Systemic Symptoms 6.0%
Vomiting 5.4%
Drug Exposure During Pregnancy 4.9%
Drug Toxicity 4.9%
Toxic Epidermal Necrolysis 4.9%
Pneumonia Aspiration 4.3%
Ventricular Tachycardia 4.3%
Rhabdomyolysis 3.8%
Swelling Face 3.8%
Withdrawal Syndrome 3.8%
Multiple Drug Overdose Intentional 3.3%
Pneumonia 3.3%
Urinary Incontinence 3.3%
Hypoplastic Right Heart Syndrome 2.7%
Maternal Drugs Affecting Foetus 2.7%
Extrapyramidal Disorder 2.2%
Intentional Overdose 2.2%
Concomitant
Drug Use For Unknown Indication 20.8%
Product Used For Unknown Indication 14.6%
Schizophrenia 12.0%
Insomnia 10.0%
Depression 6.6%
Hypertension 3.6%
Constipation 3.3%
Pain 3.3%
Epilepsy 2.9%
Infantile Spasms 2.9%
Prophylaxis 2.9%
Rheumatoid Arthritis 2.2%
Bipolar I Disorder 2.2%
Schizophrenia, Paranoid Type 2.1%
Bipolar Disorder 2.0%
Multiple Myeloma 1.8%
Osteoporosis 1.8%
Anxiety 1.8%
Muscle Spasms 1.7%
Cardiac Disorder 1.4%
Weight Increased 15.5%
Tremor 7.9%
Rhabdomyolysis 6.0%
White Blood Cell Count Decreased 6.0%
White Blood Cell Count Increased 5.3%
Convulsion 5.1%
Suicide Attempt 4.9%
Death 4.6%
Vomiting 4.6%
Hyponatraemia 4.4%
Completed Suicide 4.2%
Somnolence 4.2%
Suicidal Ideation 3.7%
Weight Decreased 3.7%
Overdose 3.5%
Pancytopenia 3.5%
Drug Ineffective 3.2%
Pulmonary Embolism 3.2%
Pyrexia 3.2%
Rash 3.2%
Interacting
Product Used For Unknown Indication 43.5%
Schizophrenia 23.2%
Constipation 6.5%
Parkinson's Disease 4.3%
Bipolar I Disorder 3.6%
Depression 3.6%
Pneumonia 2.9%
Hepatitis C 2.2%
Insomnia 2.2%
Poor Quality Sleep 2.2%
Anaesthesia 1.4%
Hypertension 1.4%
Pain 1.4%
Cardiac Failure 0.7%
Smoking Cessation Therapy 0.7%
Withdrawal Syndrome 27.8%
Fall 11.1%
Peritonitis 11.1%
Sleep Disorder 11.1%
Condition Aggravated 5.6%
Drug Interaction 5.6%
Hallucination, Auditory 5.6%
Ileus Paralytic 5.6%
Insomnia 5.6%
Sepsis 5.6%
Unevaluable Event 5.6%